Browse studies

Find your next paid study

5 recruiting studies matching your filters

Feasibility Study of Time Restricted Eating and a Healthy Diet in Patients Receiving Liver-Directed Therapy for Hepatocellular Carcinoma

This is a feasibility study that will collect data to assess the potential effect of nutritional intervention. This prospective single-site trial will enroll a…

Liver Cancer, AdultMASH - Metabolic Dysfunction-Associated SteatohepatitisObesity and Overweight

Estimated

~$10 – $750

Actual pay is set by the research site.

University of California, San DiegoNCT06824974

Phase 2

Utilizing Parenchymal Blood Volume Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin

This is a single-arm, open-label, single-center, first-in-human feasibility study evaluating parenchymal blood volume (PBV) imaging as a tool to dynamically as…

Hepatocellular Carcinoma (HCC)Liver Cancer, Adult

Estimated

~$75 – $1,800

Actual pay is set by the research site.

University of California, San FranciscoNCT07682454

Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients With Abdominal and Pelvic Tumors Undergoing Therapy

This clinical trial studies how well 3-dimensional multi-parametric ultrasound (3D MPUS) imaging works as a decision-support tool for patients with liver tumor…

Liver Cancer, Adult

Estimated

~$10 – $750

Actual pay is set by the research site.

University of California, San DiegoNCT05705219

Observational

A ProSPEctivE Study of NGDS DMAT Workflow Feasibility

The purpose of this research is to evaluate the "Next Generation Delivery System" (NGDS) and determine if this machine will be more efficient at delivering rad…

Lung Cancer (Diagnosis)Liver Cancer, AdultPancreatic Cancer+2 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Varian, a Siemens Healthineers CompanyNCT07824583

Phase 1

An Open-Label, Dose Escalation, Multi-Center Phase I/II Clinical Trial of ECT204 T-Cell Therapy in Adults With Advanced Hepatocellular Carcinoma (HCC)

This is an open-label, multi-center, Phase 1/2 clinical trial evaluating the safety, tolerability, and efficacy of ECT204, an investigational ARTEMIS® T-cell t…

Hepatocellular CarcinomaLiver Cancer, AdultLiver Neoplasm+1 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Eureka Therapeutics Inc.NCT04864054